Page last updated: 2024-11-01

nevirapine and Hepatitis B, Chronic

nevirapine has been researched along with Hepatitis B, Chronic in 1 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Hepatitis B, Chronic: INFLAMMATION of the LIVER in humans caused by HEPATITIS B VIRUS lasting six months or more. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Maat, MM1
Mathôt, RA1
Veldkamp, AI1
Huitma, AD1
Mulder, JW1
Meenhorst, PL1
Van Gorp, EC1
Carlier, H1
Beijnen, JH1

Other Studies

1 other study available for nevirapine and Hepatitis B, Chronic

ArticleYear
Hepatotoxicity following nevirapine-containing regimens in HIV-1-infected individuals.
    Pharmacological research, 2002, Volume: 46, Issue:3

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Bilirubin; Female; Hepati

2002